Watch Ticker

C4 Therapeutics, Inc.

Go to C4 Therapeutics, Inc. Website

$2.00

-0.10 (-4.70%)

Live

Previous Close

$2.1

Day Range

$2 - $2.13

Previous Day Range

$2.04 - $2.155

Market Cap

$150.5 million USD

Day Vol.

845740

Previous Day Vol.

1.2 million

Currency

USD

Primary Exchange

Nasdaq

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targe...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

C4 Therapeutics - C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights

C4 Therapeutics reported positive data for its multiple myeloma drug candidate cemsidomide, with a 50% overall response rate at the highest dose level. The company is prioritizing the development of cemsidomide and plans to seek partnership opportunities for its BRAF program.

Related tickers: CCCC, RHHBY.

Read Full Article

Delveinsight - BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight

The BRAF inhibitor market is expected to grow significantly due to the increasing number of cancer patients, rise in biomarker testing, and ongoing research and development of next-generation BRAF-targeting therapies.

Related tickers: PFE, NVS, RHHBY, CCCC, BDTX.

Read Full Article

Trending Tickers

Please sign in to view